DK95284A - Krystalliseret kulhydratmatrix for biologisk aktive stoffer, fremgangsmaade til fremstilling deraf samt dens anvendelse - Google Patents

Krystalliseret kulhydratmatrix for biologisk aktive stoffer, fremgangsmaade til fremstilling deraf samt dens anvendelse Download PDF

Info

Publication number
DK95284A
DK95284A DK95284A DK95284A DK95284A DK 95284 A DK95284 A DK 95284A DK 95284 A DK95284 A DK 95284A DK 95284 A DK95284 A DK 95284A DK 95284 A DK95284 A DK 95284A
Authority
DK
Denmark
Prior art keywords
procedures
production
application
biologically active
active substances
Prior art date
Application number
DK95284A
Other languages
Danish (da)
English (en)
Other versions
DK95284D0 (da
Inventor
Ulf Schroeder
Original Assignee
Ulf Schroeder
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ulf Schroeder filed Critical Ulf Schroeder
Publication of DK95284A publication Critical patent/DK95284A/da
Publication of DK95284D0 publication Critical patent/DK95284D0/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK0952/84A 1982-07-09 1984-02-23 Krystalliseret kulhydratmatrix for biologisk aktive stoffer, fremgangsmade til fremstilling deraf samt dens anvendelse DK95284D0 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8204244A SE8204244L (sv) 1982-07-09 1982-07-09 Kristalliserad kolhydratsmatris for biologiskt aktiva substanser
PCT/SE1983/000268 WO1984000294A1 (en) 1982-07-09 1983-07-04 A crystallised carbohydrate matrix for biologically active substances, a process of preparing said matrix, and the use thereof

Publications (2)

Publication Number Publication Date
DK95284A true DK95284A (da) 1984-02-23
DK95284D0 DK95284D0 (da) 1984-02-23

Family

ID=20347337

Family Applications (1)

Application Number Title Priority Date Filing Date
DK0952/84A DK95284D0 (da) 1982-07-09 1984-02-23 Krystalliseret kulhydratmatrix for biologisk aktive stoffer, fremgangsmade til fremstilling deraf samt dens anvendelse

Country Status (9)

Country Link
EP (1) EP0113749B1 (fi)
JP (1) JPS59501213A (fi)
AU (1) AU567434B2 (fi)
DE (1) DE3376797D1 (fi)
DK (1) DK95284D0 (fi)
FI (1) FI840923A0 (fi)
NO (1) NO840676L (fi)
SE (1) SE8204244L (fi)
WO (1) WO1984000294A1 (fi)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5720939A (en) * 1985-08-15 1998-02-24 Nycomed Imaging As Method of contrast enhanced magnetic resonance imaging using magnetically responsive-particles
US5618514A (en) * 1983-12-21 1997-04-08 Nycomed Imaging As Diagnostic and contrast agent
JPS60175539A (ja) * 1984-02-23 1985-09-09 Snow Brand Milk Prod Co Ltd カプセル体およびその製造法
US5266333A (en) * 1985-03-06 1993-11-30 American Cyanamid Company Water dispersible and water soluble carbohydrate polymer compositions for parenteral administration of growth hormone
US5075109A (en) * 1986-10-24 1991-12-24 Southern Research Institute Method of potentiating an immune response
US6024983A (en) * 1986-10-24 2000-02-15 Southern Research Institute Composition for delivering bioactive agents for immune response and its preparation
US4925678A (en) * 1987-04-01 1990-05-15 Ranney David F Endothelial envelopment drug carriers
US5707604A (en) * 1986-11-18 1998-01-13 Access Pharmaceuticals, Inc. Vivo agents comprising metal-ion chelates with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles
US5672334A (en) * 1991-01-16 1997-09-30 Access Pharmaceuticals, Inc. Invivo agents comprising cationic metal chelators with acidic saccharides and glycosaminoglycans
US5108759A (en) * 1987-04-01 1992-04-28 Ranney David F Endothelial envelopment drug carriers
SE8701479L (sv) * 1987-04-09 1988-10-10 Carbomatrix Ab Metod foer inneslutning av biologiskt verksamma preparat samt anvaendning daerav
US5399363A (en) * 1991-01-25 1995-03-21 Eastman Kodak Company Surface modified anticancer nanoparticles
US5145684A (en) * 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
AU642066B2 (en) * 1991-01-25 1993-10-07 Nanosystems L.L.C. X-ray contrast compositions useful in medical imaging
SE9302777D0 (sv) * 1993-08-27 1993-08-27 Astra Ab Process for conditioning substances
US5874063A (en) * 1991-04-11 1999-02-23 Astra Aktiebolag Pharmaceutical formulation
DK0586524T3 (fi) * 1991-06-03 1997-05-20 Nycomed Imaging As
GB9116610D0 (en) * 1991-08-01 1991-09-18 Danbiosyst Uk Preparation of microparticles
FR2692168B1 (fr) * 1992-06-16 1995-03-24 Centre Nat Rech Scient Préparation et utilisation de nouveaux systèmes colloïdaux dispersibles à base de cyclodextrine, sous forme de nanosphères.
KR100419037B1 (ko) * 1994-03-07 2004-06-12 넥타르 테라퓨틱스 폐를통한인슐린의전달방법및그조성물
US5912000A (en) * 1994-09-23 1999-06-15 Zonagen, Inc. Chitosan induced immunopotentiation
ATE223235T1 (de) * 1994-09-23 2002-09-15 Zonagen Inc Chitosan induzierte verstärkung
US6106866A (en) * 1995-07-31 2000-08-22 Access Pharmaceuticals, Inc. In vivo agents comprising cationic drugs, peptides and metal chelators with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles, including tumor sites
GB9526392D0 (en) 1995-12-22 1996-02-21 Glaxo Group Ltd Medicaments
IT1297461B1 (it) * 1997-10-29 1999-12-17 Ciocca Maurizio Preparazione di compresse a rilascio controllato a base di complessi tra carragenano e farmaci basici solubili
EP1184032A1 (en) * 2000-08-31 2002-03-06 OctoPlus B.V. Dextran hydrogels
EP1356826A1 (en) 2002-04-22 2003-10-29 BIOMAY Produktions- und Handels- Aktiengesellschaft Microparticles comprising carbohydrate beads covalently linked with allergen
TW200529869A (en) * 2003-03-04 2005-09-16 Technology Dev Company Ltd Delivery system for drug and cell therapy
EP1576952A1 (en) * 2004-03-18 2005-09-21 OctoPlus Technologies B.V. Hydrogel microspheres with improved release profile
SE0600091L (sv) * 2006-01-18 2007-04-17 Bows Pharmaceuticals Ag Förfarande för framställning av en dextranmatris för kontrollerad frisättning av insulin

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52136911A (en) * 1976-05-06 1977-11-16 Eisai Co Ltd Solid ubidecarenone agent
JPS603998B2 (ja) * 1977-04-19 1985-01-31 凸版印刷株式会社 合成樹脂成形物への加熱転写法
JPS5547615A (en) * 1978-09-29 1980-04-04 Taiyo Yakuhin Kogyo Kk Stable solid drug of nifedipine
SE445013B (sv) * 1979-06-21 1986-05-26 Landstingens Inkopscentral Medel for att forebygga eller behandla infektioner hos menniskor och djur
DE2925009A1 (de) * 1979-06-21 1981-01-08 Basf Ag Zubereitung fuer substanzen, verfahren zu deren herstellung und deren verwendung
DE3147714A1 (de) * 1981-11-27 1983-06-01 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue prostacycline und verfahren zu ihrer herstellung
US5855764A (en) * 1997-07-15 1999-01-05 Exxon Research And Engineering Company Method for demetallating petroleum streams

Also Published As

Publication number Publication date
SE8204244L (sv) 1984-01-10
WO1984000294A1 (en) 1984-02-02
FI840923A (fi) 1984-03-07
AU567434B2 (en) 1987-11-19
AU1776083A (en) 1984-02-08
DK95284D0 (da) 1984-02-23
JPS59501213A (ja) 1984-07-12
EP0113749B1 (en) 1988-06-01
SE8204244D0 (sv) 1982-07-09
FI840923A0 (fi) 1984-03-07
DE3376797D1 (en) 1988-07-07
EP0113749A1 (en) 1984-07-25
NO840676L (no) 1984-02-22

Similar Documents

Publication Publication Date Title
DK95284A (da) Krystalliseret kulhydratmatrix for biologisk aktive stoffer, fremgangsmaade til fremstilling deraf samt dens anvendelse
NO854047L (no) Avgivningssystem for to eller flere aktive stoffer.
NO851881L (no) Innretning for avgivelse av flyktige, virksomme materialer.
DE3782394D1 (de) Immobilisiertes, physiologisch aktives material.
NO845223L (no) Flerlag-arkstruktur, fremgangsmaate for dens fremstilling, og beholdere fremstilt derav.
DE3579888D1 (de) Carbapenemverbindungen und deren herstellung.
DK53491A (da) Ikke-vaevede stoffer samt fremgangsmaade til fremstillingen deraf
DE3884891D1 (de) Aktive Matrixzelle und deren Herstellungsverfahren.
DK457288D0 (da) Kapsel til farmaceutisk virksomme stoffer
AU8511582A (en) Relubricatable double row bearing
DE69014166D1 (de) Aktive Matrix.
JPS57132191A (en) Active matrix substrate
FI852512L (fi) Farmakologiskt aktiva substituerade benzamider.
NO871292L (no) Materialbane, saerlig til filtreringsformaal, fremgangsmaate for dens fremstilling samt for dens anvendelse.
IT8420862A0 (it) Impianto di alimentazione e controllo del cioccolato per raffinatrici di cioccolato.
NO881386D0 (no) Forstoff, samt fremstilling derav.
FR2518091B1 (fr) 23-dehydro-25-hydroxyvitamine d3, son procede de preparation et composition pharmaceutique la renfermant
FI870334A (fi) Arkliknande material foer foerhindrande av korrosion pao jaernmetall.
FI841649A0 (fi) Biologiskt aktiva polypeptider.
FR2558171B1 (fr) Materiau polymerique a action enzymatique, son procede de preparation et son utilisation en tant que medicament
DE3280087D1 (de) Granuliertes duengemittel mit gesteuerter wirkstofffreigabe.
IT1209660B (it) 7-ossomitosani sostituiti aventi azione quali antibiotici.
NL186447B (nl) Verbinding met anti-ulcerogene activiteit, werkwijze voor het bereiden daarvan en farmaceutische preparaten die deze stof bevatten.
NO166648C (no) Halogenert butylgummi, fremgangsmaate for dens fremstilling samt anvendelse derav.
OA07046A (fr) Esters phénoxypyridyllméthyliques, leur procédé de production et leur utilisation dans des compositions pesticides.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment